Intermediate-scale benchtop bioreactor protocol streamlines production of iPSC-derived macrophages for research, drug discovery, and modeling.

The addition of the 50-liter single-use bioreactor significantly expands Cellipont's cGMP-compliant capacity, enabling clients to seamlessly transition from early development to large-scale, ...

BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy Bioreactor (ATB™) – a revolutionary platform ...

Fermentation has evolved into precision fermentation, utilizing biotechnology to engineer microorganisms that produce ...

The demand for producing therapeutic recombinant proteins is generating a renewed interest in perfusion cell culture technologies, leading to the development of cell culture media that can support ...

Construction is expected to start in the second half of 2026, with commercialization in 2028, says Unibio CEO David Henstrom.

Southwest Research Institute (SwRI) has demonstrated a new application for its cell-expansion bioreactor to advance tissue engineering and cell-based therapies for treatment of injuries and diseases.

Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

The MarketWatch News Department was not involved in the creation of this content. THE WOODLANDS, Texas, Dec. 2, 2025 /PRNewswire/ -- Cellipont Bioservices, a leading cell therapy Contract Development ...